Meridian Bioscience to Present at the UBS Global Life Science Conference
CINCINNATI--(BUSINESS WIRE)--Sept. 20, 2007--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that the Company has been invited to present at the UBS Global Life Science Conference at the Grand Hyatt New York in New York City. Bill Motto, Chairman and CEO and Jack Kraeutler, President and COO, are scheduled to present on Wednesday, September, 26, 2007 at 2:00 p.m. ET. A question and answer session will follow and some of the information provided during the session may not have been previously disclosed. Mr. Motto and Mr. Kraeutler will be available to meet with investors during the Conference.
Meridian invites investors to listen to management's remarks, live over the Internet at 2:00 p.m. ET on September 26 on the Company's website, www.meridianbioscience.com, under Events and Presentations on the Investors Relations page. The archived broadcast will be available at 5:00 p.m. ET on September 26, 2007 until October 27, 2007.
Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products and diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral and respiratory infections. Meridian's diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents, specialty biologicals and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products and technologies to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers and biotech companies in more than 60 countries around the world. The Company's shares are traded through NASDAQ's Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, President, 513-271-3700
SOURCE: Meridian Bioscience, Inc.